Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that ...

Merck MRK announced that it has entered into an exclusive licensing deal with China-based privately-held biotech company ...

Health stocks slumped on Friday as Wall Street weighed the impact that prominent vaccine skeptic Robert F. Kennedy Jr. could ...

The third-quarter earnings season came to an end this week for large drugmakers, with AstraZeneca AZN and Bayer BAYRY ...

Kennedy believes that vaccines cause autism and wants to use his perch to carry out further testing.

President-elect Donald Trump has announced he wants to appoint vaccine sceptic Robert F Kennedy Jr as the head of the US ...

Merck (MRK) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP, adopted an opinion ...

The Dow Jones Industrial Average (DJIA), one of the three main Wall Street benchmarks, succumbed to selling pressure in early ...

Shares of Merck Merck & Co. Inc. and Amgen Amgen Inc. are contributing to the blue-chip gauge's intraday decline, as the Dow Dow Jones Industrial Average was most recently trading 168 points, or 0.4%, ...

Liquidia's collaboration on L606 boosts long-term growth potential. Find out why LQDA stock’s valuation and upcoming launches ...

Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.

The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...